ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCOG Still Alive, But Not Without Fight On NCAB In Test Of Regional Cooperative Group Concept

May 22, 1981

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

Guest Editorial: Guideline Promises to End Twenty-Year War Over Mass Screening for Prostate Cancer

May 24, 2013

Also Unclear whether HHS Secretary Tommy Thompson will depart as previously planned.

November 5, 2004

“Tone” Of Statement Lacks Balance, Klausner Says

January 31, 1997

Abstracts Of Papers From Gynecologic Oncology Conference

October 10, 1975